RecruitingNCT06188065

Eosinopenia in Severe COPD Exacerbation

Associates of, and Time to Recovery From, Eosinopenia in Severe COPD Exacerbation


Sponsor

Northumbria Healthcare NHS Foundation Trust

Enrollment

200 participants

Start Date

Jan 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The goals of this observational study are to identify factors independently associated with admission eosinopenia in patients with a severe exacerbation of chronic obstructive pulmonary disease (COPD) and to determine when blood eosinophil count (BEC) will recover to baseline stable state in patients who are admitted to hospital with a severe exacerbation of COPD and associated eosinopenia. The main aims of the study are to: 1. Identify demographic, physiological and clinical factors independently associated with admission eosinopenia in patients with a severe exacerbation of COPD 2. Assess the time to recovery from eosinopenia to stable BEC following a severe exacerbation of COPD


Eligibility

Min Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This observational study looks at whether having a low eosinophil count in the blood (eosinopenia) at hospital admission can predict the severity of a COPD flare-up (exacerbation). COPD is a chronic lung disease that causes breathing problems, and flare-ups can be serious. **You may be eligible if...** - You have been admitted to hospital primarily because of a COPD exacerbation (a significant worsening of breathing) - You have a smoking history of at least 10 pack years - You have confirmed airflow obstruction on breathing tests (FEV1/FVC ratio below 0.7) - You are able to give informed consent **You may NOT be eligible if...** - You have an active parasitic or systemic fungal infection - You are currently taking medications that significantly affect eosinophil counts (such as steroids) - You have other serious conditions that the investigator believes would confound the results Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood eosinophil count

To determine the time it takes for blood eosinophil count to recover to baseline stable state following severe exacerbation of COPD associated with admission eosinopenia and to explore independent factors associated with admission eosinopenia.


Locations(1)

Northumbria Healthcare NHS Foundation Trust

North Shields, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06188065


Related Trials